This study aimed to determine the effects of different doses of culture (ATC) on lactation performance, immune function, antioxidant capacity, and intestinal flora of sows. Forty-five Landrace sows (3-6 parity) were randomly assigned to the following three treatments from 85 days of gestation to 21 days after farrowing: a control diet (CON, basal diet), a low-dose culture diet (0.2% ATC, basal diet + 0.2% ATC), and a high-dose culture diet (0.4% ATC, basal diet + 0.4% ATC). Compared with the CON group, the supplementation of 0.2% ATC increased the average daily milk yield of sows by 4.98%, increased milk fat, total solids, and freezing point depression on day 1 postpartum ( < 0.05), increased serum concentration of Triiodothyronine, Thyroxin, and Estradiol on day 21 postpartum ( < 0.05). Compared with the CON group, the supplementation of 0.4% ATC increased the average daily milk yield of sows by 9.38% ( < 0.05). Furthermore, the supplementation of 0.2% ATC increased serum concentration of IgG, IgM, and IFN-γ, CD4 on day 1 postpartum ( < 0.05) and increased serum concentration of immunoglobulin A ( IgA), immunoglobulin G (IgG), immunoglobulin M ( IgM), complement 3 (C3), cluster of differentiation 4 (CD4), cluster of differentiation 8 (CD8), interferon-γ (IFN-γ) on day 21 postpartum ( < 0.05), while the supplementation of 0.4% ATC reduced serum concentration of IL-2 on day 21 postpartum ( < 0.05). Moreover, the supplementation of 0.4% ATC significantly increased serum concentration of catalase (CAT) ( < 0.05). Additionally, the supplementation of ATC affected the relative abundance of the intestinal flora at different taxonomic levels in sows and increased the abundance of beneficial bacteria such as in the , , and of sows, while reducing the abundance of harmful bacteria such as and . These data revealed that the supplementation of ATC during late gestation and lactation can improve lactation performance, immune function, antioxidant capacity, and the gut microbiota. Compared with supplementation of 0.4% ATC, 0.2% ATC enhances the levels of thyroid-related hormones, specific antibodies, and cytokines in serum, promotes the diversity of beneficial gut microbiota, beneficial bacteria in the intestine, reduces the population of harmful bacteria, and thereby bolsters the immunity of sows. Hence, 0.2% ATC is deemed a more optimal concentration.

Download full-text PDF

Source
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC11352107PMC
http://dx.doi.org/10.3390/antiox13080970DOI Listing

Publication Analysis

Top Keywords

02% atc
24
04% atc
24
day postpartum
20
postpartum 005
20
serum concentration
20
atc increased
16
increased serum
16
supplementation 04%
16
atc
15
lactation performance
12

Similar Publications

Interleukin-10 (IL-10) is an immunomodulatory molecule that may play an immunosuppressive role in nonmelanoma skin cancer (NMSC), specifically basal cell carcinoma (BCC). We analyzed the role of IL10 promoter variants in genetic determinants of BCC susceptibility and their association with IL10 mRNA and IL-10 serum levels. Three promoter variants (- 1082 A > G, - 819 T > C, and - 592 A > C) were examined in 250 BCC patients and 250 reference group (RG) individuals.

View Article and Find Full Text PDF

Background: Although thyroid cancer is associated with low mortality rates, significant racial disparities in thyroid cancer outcomes have not been adequately studied in Asia. Moreover, the Asian population consists of different ethnic groups that are not homogeneous. This study aimed to perform a population-based analysis of survival outcomes and prognostic factors in thyroid cancer patients.

View Article and Find Full Text PDF
Article Synopsis
  • Researchers developed a new, cost-effective micromixing technique for creating liposome nanoformulations, comparing it to the conventional thin-film hydration (TFH) method.
  • The study used simulations and experimental design to determine optimal conditions for producing anionic liposomes, with both methods resulting in similar properties such as size, encapsulation efficiency, and stability.
  • The micromixing method offers a one-step production process that is highly controllable, reproducible, and compatible with various solvents, making it a versatile alternative for nanoliposome manufacturing.
View Article and Find Full Text PDF

Antibiotic Use and Subsequent Cognitive Decline and Dementia Risk in Healthy Older Adults.

Neurology

January 2025

From the Clinical and Translational Epidemiology Unit (Y.W., A.T.C.), and Division of Gastroenterology (Y.W., A.T.C.), Massachusetts General Hospital and Harvard Medical School, Boston; School of Public Health and Preventive Medicine (Z.Z., J.C.B., R.L.W., S.G.O., R.W., J.R.), Monash University, Melbourne; Menzies Institute for Medical Research (Z.Z.), University of Tasmania, Australia; Department of Pharmacy Practice and Science (E.J.E.. M.E.E.), College of Pharmacy, and Department of Family Medicine (M.E.E.), Carver College of Medicine, University of Iowa, Iowa City; Department of Immunology and Infectious Diseases (A.T.C.), Harvard T.H. Chan School of Public Health, Boston; and Cancer Center (A.T.C.), Massachusetts General Hospital, Boston, MA.

Background And Objectives: Antibiotics rapidly reduce intestinal bacterial diversity, leading to dysbiosis that persists for months to years. Although emerging evidence from retrospective and claims-based studies has linked dysbiosis to cognitive function, prospective data are lacking. We aim to examine the prospective association of antibiotics with cognitive aging among initially healthy older adults.

View Article and Find Full Text PDF

YTHDF2 promotes anaplastic thyroid cancer progression by activating the DDIT4/AKT/mTOR signaling pathway.

Biol Direct

November 2024

Department of Thyroid and Hernia Surgery, Guangdong Provincial People's Hospital, Guangdong Academy of Medical Sciences, Southern Medical University, Guangzhou, Guangdong, 510080, China.

Article Synopsis
  • YTHDF2 is a key player in anaplastic thyroid cancer (ATC), with its expression significantly increased in cancerous tissues.
  • Research reveals that when YTHDF2 is knocked down, it inhibits ATC cell growth and metastasis, while overexpression of YTHDF2 has the opposite effect.
  • The mechanism involves YTHDF2 promoting the degradation of DDIT4 mRNA, leading to activation of the AKT/mTOR signaling pathway, which in turn drives tumor progression in ATC.
View Article and Find Full Text PDF

Want AI Summaries of new PubMed Abstracts delivered to your In-box?

Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!